Clinical Trial Update: Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

This Phase 2 extension study reports results comparing two dosing schedules of adalimumab in adults with moderate-to-severe chronic plaque psoriasis, and the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 2 | Status: COMPLETED